APA (7th ed.) Citation

J, E., J, W., K, B., M, B., C, J., LC, S., . . . TL, P. (2022). Restoring mortality data in the FOURIER cardiovascular outcomes trial of evolocumab in patients with cardiovascular disease: A reanalysis based on regulatory data. BMJ open, 12(12), e060172. https://doi.org/10.1136/bmjopen-2021-060172

Chicago Style (17th ed.) Citation

J, Erviti, Wright J, Bassett K, Ben-Eltriki M, Jauca C, Saiz LC, Leache L, Gutiérrez-Valencia M, and Perry TL. "Restoring Mortality Data in the FOURIER Cardiovascular Outcomes Trial of Evolocumab in Patients with Cardiovascular Disease: A Reanalysis Based on Regulatory Data." BMJ Open 12, no. 12 (2022): e060172. https://doi.org/10.1136/bmjopen-2021-060172.

MLA (9th ed.) Citation

J, Erviti, et al. "Restoring Mortality Data in the FOURIER Cardiovascular Outcomes Trial of Evolocumab in Patients with Cardiovascular Disease: A Reanalysis Based on Regulatory Data." BMJ Open, vol. 12, no. 12, 2022, p. e060172, https://doi.org/10.1136/bmjopen-2021-060172.